Central Trust CO Sarepta Therapeutics, Inc. Transaction History
Central Trust CO
- $4 Billion
- Q4 2024
A detailed history of Central Trust CO transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Central Trust CO holds 113 shares of SRPT stock, worth $12,198. This represents 0.0% of its overall portfolio holdings.
Number of Shares
113
Previous 113
-0.0%
Holding current value
$12,198
Previous $14,000
7.14%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding SRPT
# of Institutions
535Shares Held
89.8MCall Options Held
1.66MPut Options Held
1.44M-
Black Rock Inc. New York, NY10.3MShares$1.11 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.09MShares$981 Million0.02% of portfolio
-
Capital International Investors Los Angeles, CA8.7MShares$939 Million0.21% of portfolio
-
Janus Henderson Group PLC London, X04.33MShares$467 Million0.28% of portfolio
-
State Street Corp Boston, MA4.07MShares$439 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $9.45B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...